<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied a group of patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) for surface markers and cytotoxic activities of peripheral blood mononuclear cells (PBMNC) </plain></SENT>
<SENT sid="1" pm="."><plain>The results indicate a significant increase in the total count of CD11b+, Leu7+ and CD16+ with a percent reduction in CD4+ </plain></SENT>
<SENT sid="2" pm="."><plain>A reduction in PHA-induced cellular cytotoxicity (PHA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICC</z:e>) and NK activity were found </plain></SENT>
<SENT sid="3" pm="."><plain>A similar phenotype was found both in <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) and (RA) with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) </plain></SENT>
<SENT sid="4" pm="."><plain>However, the functional activities reached the <z:mpath ids='MPATH_458'>normal</z:mpath> level only in RA patients; while in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t patients a significant reduction was detected in PHA-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICC</z:e> and NK activity </plain></SENT>
</text></document>